ESPR - Esperion Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ESPR is currently covered by 8 analysts with an average price target of $13.49. This is a potential upside of $12.27 (1005.74%) from yesterday's end of day stock price of $1.22.

Esperion Therapeutics's activity chart (see below) currently has 210 price targets and 193 ratings on display. The stock rating distribution of ESPR is 87.18% BUY, 7.69% HOLD and 5.13% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 39.98% with an average time for these price targets to be met of 123.82 days.

Highest price target for ESPR is $16, Lowest price target is $2.5, average price target is $5.92.

Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 25-Apr-2025. First documented stock forecast 27-Oct-2014.

Currently out of the existing stock ratings of ESPR, 34 are a BUY (87.18%), 3 are a HOLD (7.69%), 2 are a SELL (5.13%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$16

$14.91 (1367.89%)

$16

1 months 13 days ago
(25-Apr-2025)

0/5 (0%)

$15.08 (1639.13%)

Buy

$5

$3.91 (358.72%)

$5

1 months 13 days ago
(25-Apr-2025)

0/12 (0%)

$4.08 (443.48%)

Buy

$4

$2.91 (266.97%)

3 months 2 days ago
(05-Mar-2025)

1/12 (8.33%)

$2.35 (142.42%)

255

Buy

$4

$2.91 (266.97%)

$7

3 months 27 days ago
(11-Feb-2025)

0/3 (0%)

$2.21 (123.46%)

Hold

$4

$2.91 (266.97%)

$3.5

5 months 20 days ago
(18-Dec-2024)

8/9 (88.89%)

$1.84 (85.19%)

79

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ESPR (Esperion Therapeutics) average time for price targets to be met?

On average it took 123.82 days on average for the stock forecasts to be realized with a an average price target met ratio 39.98

Which analyst has the current highest performing score on ESPR (Esperion Therapeutics) with a proven track record?

JOEL BEATTY

Which analyst has the most public recommendations on ESPR (Esperion Therapeutics)?

Joel Beatty works at BAIRD and has 11 price targets and 8 ratings on ESPR

Which analyst is the currently most bullish on ESPR (Esperion Therapeutics)?

Alex Schwartz with highest potential upside - $92.91

Which analyst is the currently most reserved on ESPR (Esperion Therapeutics)?

Martin Auster with lowest potential downside - -$0

Esperion Therapeutics in the News

Esperion to Participate in H.C. Wainwright’s 3rd Annual BioConnect Investor Conference

ANN ARBOR, Mich., May 09, 2025 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) today announced that the company will be participating in the webcasted H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20, 2025, at 10 a.m. ET. The live webcast can be accessed on the investor and media section of the Esperion website. Access...

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

ANN ARBOR, Mich., May 08, 2025 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) today announced that on May 7, 2025, the Company granted 15 new employees 49,300 restricted stock units (RSUs) under Esperion’s 2017 Inducement Equity Incentive Plan. The 2017 Inducement Equity Incentive Plan is used exclusively for the grant of equity awards to individuals who...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?